Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.05K Buy
+10,005
New +$6.05K ﹤0.01% 993
2026
Q1
Sell
-10,005
Closed -$3.47K 979
2025
Q4
$3.47K Buy
+10,005
New +$3.47K ﹤0.01% 866
2025
Q3
Sell
-20,005
Closed -$9.04K 848
2025
Q2
$9.04K Hold
20,005
﹤0.01% 743
2025
Q1
$7.8K Sell
20,005
-10,000
-33% -$6.41K ﹤0.01% 721
2024
Q4
$19.9K Buy
+30,005
New +$20.8K ﹤0.01% 779
2024
Q3
Sell
-25,000
Closed -$16.7K 761
2024
Q2
$16.7K Hold
25,000
﹤0.01% 652
2024
Q1
$32.5K Buy
+25,000
New +$26.2K ﹤0.01% 611

Other funds holding VXRT

Kingswood Wealth Advisors's VXRT Position: Q2 2026 in Review

Kingswood Wealth Advisors opened a new position in Vaxart (VXRT) in Q2 2026: 10,005 shares worth $6.05K. The stake represents ﹤0.01% of the portfolio and ranks #993 among its holdings. This is a return to the name: Kingswood Wealth Advisors previously reported a position in VXRT as recently as Q4 2025.

Kingswood Wealth Advisors first reported a position in VXRT in Q1 2024 and has held it in 7 quarters since. The position peaked at $32.5K in Q1 2024. 4 funds tracked by Wall St. Rank hold VXRT as of Q2 2026.

  • Kingswood Wealth Advisors held 10,005 shares of Vaxart worth $6.05K as of Q2 2026.
  • Vaxart was a new Kingswood Wealth Advisors position in Q2 2026.
  • Vaxart made up ﹤0.01% of Kingswood Wealth Advisors's portfolio in Q2 2026, its #993 holding.
  • Kingswood Wealth Advisors first reported a position in Vaxart in Q1 2024 and has held it in 7 quarters since.
  • Kingswood Wealth Advisors's Vaxart position peaked at $32.5K in Q1 2024.
  • 4 funds tracked by Wall St. Rank held Vaxart as of Q2 2026.

Based on Kingswood Wealth Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.